MEMSCAP’ large and growing number of Fortune 500 customers, innovative start ups, partners and design wins are testimony to the superiority of our MEMS expertise. It is built on a solid foundation of technology, innovation, and experience, delivering advantages and differentiation in performance, time to market, and reliability.
Our achievements in performance and reliability are recognized around the world and have been proven over the last decade by real conditions data from the different fields of use. MEMSCAP is the source of high-added value MEMS devices and technology and your best MEMS partner.
Learn more on some of our customers and partners’ most recent news and press releases below.
When clicking on the links below, you will be leaving the MEMSCAP website and will be redirected to another webpage on the web. MEMSCAP is not responsible for content on otherwebsites.
FDA approves CardioMEMS CHF device... more
Given Imaging Receives FDA Clearance for PillCam(R) COLON in Patients Following Incomplete Colonoscopy... more
First artificial heart implant for CARMAT ... more
CardioMEMS Wins 2012 Intel Innovation Award ... more
Given Imaging Submits PillCam(R) COLON 2 Application to FDA for U.S. Regulatory Clearance... more
Given Imaging Submits PillCam(R) COLON 2 Pivotal Trial Data to Japan's PMDA for Approval... more
Given Imaging begins pivotal Japanese colon trial... more
CardioMEMS will meet with the FDA's Circulatory Systems Devices Panel in December 2011 ... more
Building human hearts on an assembly line. In one year the share price of Carmat, the Paris-based company that is... more
Given Imaging Pushes Forward with PillCam COLON Trials. Given Imaging GIVN provided solid performance in the second quarter... more